| Coral Denise Heard, ANP | |
|
115 Wrights St, Hot Springs, AR 71913-6240 | |
| (501) 321-9803 | |
| (501) 321-0710 |
| Full Name | Coral Denise Heard |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 13 Years |
| Location | 115 Wrights St, Hot Springs, Arkansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023378783 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | A03685 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baptist Health Medical Center-arkadelphia | Arkadelphia, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Baptist Health | 0648177949 | 71 |
News Archive
Merge Healthcare, a leading provider of enterprise imaging and interoperability solutions, announced today that it has commenced an offer to exchange $52 million principal amount of its 11.75% Senior Secured Notes due 2015, which are registered under the Securities Act of 1933, for $52 million of its currently outstanding 11.75% Senior Secured Notes due 2015 that were issued in June 2011 and which have not been registered under the Securities Act of 1933.
GE Healthcare today announced results from the Tamoxifen and Exemestane Adjuvant Multinational (TEAM) Trial at the 2012 Annual Meeting of the American Society of Clinical Oncology.
Researchers may be able to develop an antidepressant which takes effect almost immediately by directly targeting novel molecules in the brain instead of taking a less direct route, which can lead to longer times for medication to take effect, according to a new study presented at the American College of Neuropsychopharmacology (ACNP) annual meeting.
The results of VOYAGER PAD found that people with peripheral artery disease (PAD) who took the blood thinner rivaroxaban with aspirin after undergoing lower extremity revascularization-a procedure to treat blocked arteries in the leg-had a significant reduction in the risk of major adverse limb and cardiovascular events when compared with those receiving aspirin alone.
› Verified 7 days ago
| Entity Name | Arkansas Health Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356481410 PECOS PAC ID: 7911802079 Enrollment ID: O20070607000040 |
News Archive
Merge Healthcare, a leading provider of enterprise imaging and interoperability solutions, announced today that it has commenced an offer to exchange $52 million principal amount of its 11.75% Senior Secured Notes due 2015, which are registered under the Securities Act of 1933, for $52 million of its currently outstanding 11.75% Senior Secured Notes due 2015 that were issued in June 2011 and which have not been registered under the Securities Act of 1933.
GE Healthcare today announced results from the Tamoxifen and Exemestane Adjuvant Multinational (TEAM) Trial at the 2012 Annual Meeting of the American Society of Clinical Oncology.
Researchers may be able to develop an antidepressant which takes effect almost immediately by directly targeting novel molecules in the brain instead of taking a less direct route, which can lead to longer times for medication to take effect, according to a new study presented at the American College of Neuropsychopharmacology (ACNP) annual meeting.
The results of VOYAGER PAD found that people with peripheral artery disease (PAD) who took the blood thinner rivaroxaban with aspirin after undergoing lower extremity revascularization-a procedure to treat blocked arteries in the leg-had a significant reduction in the risk of major adverse limb and cardiovascular events when compared with those receiving aspirin alone.
› Verified 7 days ago
| Entity Name | Arkansas Health Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447568373 PECOS PAC ID: 7911802079 Enrollment ID: O20101116000177 |
News Archive
Merge Healthcare, a leading provider of enterprise imaging and interoperability solutions, announced today that it has commenced an offer to exchange $52 million principal amount of its 11.75% Senior Secured Notes due 2015, which are registered under the Securities Act of 1933, for $52 million of its currently outstanding 11.75% Senior Secured Notes due 2015 that were issued in June 2011 and which have not been registered under the Securities Act of 1933.
GE Healthcare today announced results from the Tamoxifen and Exemestane Adjuvant Multinational (TEAM) Trial at the 2012 Annual Meeting of the American Society of Clinical Oncology.
Researchers may be able to develop an antidepressant which takes effect almost immediately by directly targeting novel molecules in the brain instead of taking a less direct route, which can lead to longer times for medication to take effect, according to a new study presented at the American College of Neuropsychopharmacology (ACNP) annual meeting.
The results of VOYAGER PAD found that people with peripheral artery disease (PAD) who took the blood thinner rivaroxaban with aspirin after undergoing lower extremity revascularization-a procedure to treat blocked arteries in the leg-had a significant reduction in the risk of major adverse limb and cardiovascular events when compared with those receiving aspirin alone.
› Verified 7 days ago
| Entity Name | Baptist Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841598919 PECOS PAC ID: 0648177949 Enrollment ID: O20110617000161 |
News Archive
Merge Healthcare, a leading provider of enterprise imaging and interoperability solutions, announced today that it has commenced an offer to exchange $52 million principal amount of its 11.75% Senior Secured Notes due 2015, which are registered under the Securities Act of 1933, for $52 million of its currently outstanding 11.75% Senior Secured Notes due 2015 that were issued in June 2011 and which have not been registered under the Securities Act of 1933.
GE Healthcare today announced results from the Tamoxifen and Exemestane Adjuvant Multinational (TEAM) Trial at the 2012 Annual Meeting of the American Society of Clinical Oncology.
Researchers may be able to develop an antidepressant which takes effect almost immediately by directly targeting novel molecules in the brain instead of taking a less direct route, which can lead to longer times for medication to take effect, according to a new study presented at the American College of Neuropsychopharmacology (ACNP) annual meeting.
The results of VOYAGER PAD found that people with peripheral artery disease (PAD) who took the blood thinner rivaroxaban with aspirin after undergoing lower extremity revascularization-a procedure to treat blocked arteries in the leg-had a significant reduction in the risk of major adverse limb and cardiovascular events when compared with those receiving aspirin alone.
› Verified 7 days ago
| Entity Name | Baptist Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780094201 PECOS PAC ID: 0648177949 Enrollment ID: O20141030001538 |
News Archive
Merge Healthcare, a leading provider of enterprise imaging and interoperability solutions, announced today that it has commenced an offer to exchange $52 million principal amount of its 11.75% Senior Secured Notes due 2015, which are registered under the Securities Act of 1933, for $52 million of its currently outstanding 11.75% Senior Secured Notes due 2015 that were issued in June 2011 and which have not been registered under the Securities Act of 1933.
GE Healthcare today announced results from the Tamoxifen and Exemestane Adjuvant Multinational (TEAM) Trial at the 2012 Annual Meeting of the American Society of Clinical Oncology.
Researchers may be able to develop an antidepressant which takes effect almost immediately by directly targeting novel molecules in the brain instead of taking a less direct route, which can lead to longer times for medication to take effect, according to a new study presented at the American College of Neuropsychopharmacology (ACNP) annual meeting.
The results of VOYAGER PAD found that people with peripheral artery disease (PAD) who took the blood thinner rivaroxaban with aspirin after undergoing lower extremity revascularization-a procedure to treat blocked arteries in the leg-had a significant reduction in the risk of major adverse limb and cardiovascular events when compared with those receiving aspirin alone.
› Verified 7 days ago
| Entity Name | Baptist Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528478955 PECOS PAC ID: 0648177949 Enrollment ID: O20141111002454 |
News Archive
Merge Healthcare, a leading provider of enterprise imaging and interoperability solutions, announced today that it has commenced an offer to exchange $52 million principal amount of its 11.75% Senior Secured Notes due 2015, which are registered under the Securities Act of 1933, for $52 million of its currently outstanding 11.75% Senior Secured Notes due 2015 that were issued in June 2011 and which have not been registered under the Securities Act of 1933.
GE Healthcare today announced results from the Tamoxifen and Exemestane Adjuvant Multinational (TEAM) Trial at the 2012 Annual Meeting of the American Society of Clinical Oncology.
Researchers may be able to develop an antidepressant which takes effect almost immediately by directly targeting novel molecules in the brain instead of taking a less direct route, which can lead to longer times for medication to take effect, according to a new study presented at the American College of Neuropsychopharmacology (ACNP) annual meeting.
The results of VOYAGER PAD found that people with peripheral artery disease (PAD) who took the blood thinner rivaroxaban with aspirin after undergoing lower extremity revascularization-a procedure to treat blocked arteries in the leg-had a significant reduction in the risk of major adverse limb and cardiovascular events when compared with those receiving aspirin alone.
› Verified 7 days ago
| Entity Name | Baptist Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518356112 PECOS PAC ID: 0648177949 Enrollment ID: O20150413001105 |
News Archive
Merge Healthcare, a leading provider of enterprise imaging and interoperability solutions, announced today that it has commenced an offer to exchange $52 million principal amount of its 11.75% Senior Secured Notes due 2015, which are registered under the Securities Act of 1933, for $52 million of its currently outstanding 11.75% Senior Secured Notes due 2015 that were issued in June 2011 and which have not been registered under the Securities Act of 1933.
GE Healthcare today announced results from the Tamoxifen and Exemestane Adjuvant Multinational (TEAM) Trial at the 2012 Annual Meeting of the American Society of Clinical Oncology.
Researchers may be able to develop an antidepressant which takes effect almost immediately by directly targeting novel molecules in the brain instead of taking a less direct route, which can lead to longer times for medication to take effect, according to a new study presented at the American College of Neuropsychopharmacology (ACNP) annual meeting.
The results of VOYAGER PAD found that people with peripheral artery disease (PAD) who took the blood thinner rivaroxaban with aspirin after undergoing lower extremity revascularization-a procedure to treat blocked arteries in the leg-had a significant reduction in the risk of major adverse limb and cardiovascular events when compared with those receiving aspirin alone.
› Verified 7 days ago
| Entity Name | Baptist Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427630110 PECOS PAC ID: 0648177949 Enrollment ID: O20210504000413 |
News Archive
Merge Healthcare, a leading provider of enterprise imaging and interoperability solutions, announced today that it has commenced an offer to exchange $52 million principal amount of its 11.75% Senior Secured Notes due 2015, which are registered under the Securities Act of 1933, for $52 million of its currently outstanding 11.75% Senior Secured Notes due 2015 that were issued in June 2011 and which have not been registered under the Securities Act of 1933.
GE Healthcare today announced results from the Tamoxifen and Exemestane Adjuvant Multinational (TEAM) Trial at the 2012 Annual Meeting of the American Society of Clinical Oncology.
Researchers may be able to develop an antidepressant which takes effect almost immediately by directly targeting novel molecules in the brain instead of taking a less direct route, which can lead to longer times for medication to take effect, according to a new study presented at the American College of Neuropsychopharmacology (ACNP) annual meeting.
The results of VOYAGER PAD found that people with peripheral artery disease (PAD) who took the blood thinner rivaroxaban with aspirin after undergoing lower extremity revascularization-a procedure to treat blocked arteries in the leg-had a significant reduction in the risk of major adverse limb and cardiovascular events when compared with those receiving aspirin alone.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Coral Denise Heard, ANP 115 Wrights St, Hot Springs, AR 71913-6240 Ph: (501) 321-9803 | Coral Denise Heard, ANP 115 Wrights St, Hot Springs, AR 71913-6240 Ph: (501) 321-9803 |
News Archive
Merge Healthcare, a leading provider of enterprise imaging and interoperability solutions, announced today that it has commenced an offer to exchange $52 million principal amount of its 11.75% Senior Secured Notes due 2015, which are registered under the Securities Act of 1933, for $52 million of its currently outstanding 11.75% Senior Secured Notes due 2015 that were issued in June 2011 and which have not been registered under the Securities Act of 1933.
GE Healthcare today announced results from the Tamoxifen and Exemestane Adjuvant Multinational (TEAM) Trial at the 2012 Annual Meeting of the American Society of Clinical Oncology.
Researchers may be able to develop an antidepressant which takes effect almost immediately by directly targeting novel molecules in the brain instead of taking a less direct route, which can lead to longer times for medication to take effect, according to a new study presented at the American College of Neuropsychopharmacology (ACNP) annual meeting.
The results of VOYAGER PAD found that people with peripheral artery disease (PAD) who took the blood thinner rivaroxaban with aspirin after undergoing lower extremity revascularization-a procedure to treat blocked arteries in the leg-had a significant reduction in the risk of major adverse limb and cardiovascular events when compared with those receiving aspirin alone.
› Verified 7 days ago
Mr. Joseph C Fendley, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1707 Airport Rd, Hot Springs, AR 71913 Phone: 501-767-6200 | |
Mrs. Susan Rachelle Robinson, MSN, APRN, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1661 Airport Rd Ste D, Hot Springs, AR 71913 Phone: 501-625-7500 | |
Laura Odle, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1629 Airport Rd Ste B, Hot Springs, AR 71913 Phone: 501-767-0075 Fax: 501-760-2739 | |
Miranda Erin Edgar, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1629 Airport Rd Ste B, Hot Springs, AR 71913 Phone: 501-767-0075 Fax: 501-760-2739 | |
Sheryl Ann Knott, AGCNS-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1455 Higdon Ferry Rd Ste B, Hot Springs, AR 71913 Phone: 501-623-2731 | |
Jerrica Lacey Luster, APRN-PMHNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3604 Central Ave Ste D, Hot Springs, AR 71913 Phone: 888-710-8220 Fax: 479-243-0285 | |
Mr. Paul M Shepard, RN, MSN, APN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1401 Malvern Ave, Room 152, Hot Springs, AR 71901 Phone: 501-624-0700 |